Drug Utilization Review (DUR)
Drug Utilization Review, or DUR, remains a steadfast component of clinical information
systems and pharmacy management systems. A requirement of OBRA '90, Drug Utilization Review enables
clinicians to view and address potential conflicts associated with a patient's drug
therapy.
Medi-Span® provides the wealth of drug information necessary to ensure a patient's
medication is optimized and safe, and the clinician is supported with accurate,
up-to-date information at every decision point.
If you are looking for tools to support Drug Utilization Review, these products
will interest you:
Databases
Adverse Drug
Effects Database™
Drug Dosing
& Administration Database™
Drug Indications
Database™
Drug Lab Conflict
Database™
Drug Therapy
Monitoring System™ (DTMS) v2.1/
DTMS Consumer Monographs
Duplicate
Therapy Database™
Integrated
A to Z Drug Facts™ Module
Master Drug
Data Base v2.5 (MDDB®)
Master Parameters
Database™
Medi-Span
Electronic Drug File™ (MED-File)
Medical Conditions
Master Database™
Medication
Order Management Database™ (MOMD)
Parameters
to Monitor Database™
Precautions
Database™
Rx Norm Cross-Reference
File
Standard Drug
Identifiers Database
Supplemental
Names File
Tools
Drug Information
Bridge™ v3.2
Integrated
Drug Facts and Comparisons™ API v3.1